{"disease":{"id":"lower-respiratory-tract-infections","name":"lower respiratory tract infections"},"drugs":{"marketed":[{"drug_id":"cefoxitin","indication_name":"Lower respiratory tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin-sodium","indication_name":"Lower respiratory tract infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CEFOXITIN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":21,"revenue":null,"mechanism":null},{"drug_id":"ceftazidime","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fortaz","generic_name":"CEFTAZIDIME","company_name":"Pai Holdings Pharm","drug_phase":"marketed","molecular_target":"","drug_class":"ceftazidime","quality_score":10,"revenue":null,"mechanism":"Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death."},{"drug_id":"amoxicillin-and-clavulanate","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amoxicillin and clavulanate","company_name":"GlaxoSmithKline","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Amoxicillin and Clavulanate Potassium is an antibacterial drug."},{"drug_id":"chembl-chembl3989564","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TOBRAMYCIN SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"cefuroxime-sodium","indication_name":"Lower Respiratory Tract Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CEFUROXIME SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Cefuroxime inhibits bacterial cell wall synthesis, acting as a bactericidal agent."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07416266","title":"Lower Respiratory Tract Infections Managed in Primary Care in France","phase":"","overall_status":"COMPLETED","enrollment_count":230066,"lead_sponsor_name":"Hôpital Raymond Poincaré","has_results":false},{"nct_id":"NCT03392363","title":"Diagnosing Respiratory Disease in Children Using Cough Sounds 2","phase":"","overall_status":"COMPLETED","enrollment_count":1470,"lead_sponsor_name":"ResApp Health Limited","has_results":false},{"nct_id":"NCT05937126","title":"Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia","phase":"","overall_status":"COMPLETED","enrollment_count":1203,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07249996","title":"Respiratory Infections in Young Children","phase":"","overall_status":"RECRUITING","enrollment_count":1088,"lead_sponsor_name":"Eduardo Lopez -Medina","has_results":false},{"nct_id":"NCT07382219","title":"Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants","phase":"","overall_status":"COMPLETED","enrollment_count":816,"lead_sponsor_name":"Han Tongyan","has_results":false},{"nct_id":"NCT07381790","title":"Modern Technologies in Lower Respiratory Tract Infections in Children","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Helse Møre og Romsdal HF","has_results":false},{"nct_id":"NCT06636890","title":"Correlation Analysis of Xpert Carba-R Detection of Non-colonized CRE in BALF and Rectal Swabs From Patients With LRTI","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05380869","title":"POCT PCT in Outpatient LRTI","phase":"NA","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Hannover Medical School","has_results":false},{"nct_id":"NCT06211985","title":"Copeptin: Disease Severity Indicator","phase":"NA","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Berker Okay","has_results":false},{"nct_id":"NCT06201494","title":"Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT06149494","title":"RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Altesa Biosciences, Inc.","has_results":false}],"total":11},"guidelines":[{"drug_id":"ceftriaxone","guideline_body":"FDA label","recommendation":"Ceftriaxone is indicated for the treatment of lower respiratory tract infections caused by susceptible organisms.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}